Table 1.
Groups | Number of cases | ALT (IU/L) | AST (IU/L) |
---|---|---|---|
Healthy control group | 10 | 21.6 (11.1~37.8) | 21.2 (17.3~33.6) |
Benign SPNs group | 12 | 28.8 (16.8~36.5) | 26.6 (18.3~31.3) |
Malignant SPNs group | 30 | 24.2 (16.1~38.1) | 25.6 (13.6~38.6) |
Groups | Number of cases | ALT (IU/L) | AST (IU/L) |
---|---|---|---|
Healthy control group | 10 | 21.6 (11.1~37.8) | 21.2 (17.3~33.6) |
Benign SPNs group | 12 | 28.8 (16.8~36.5) | 26.6 (18.3~31.3) |
Malignant SPNs group | 30 | 24.2 (16.1~38.1) | 25.6 (13.6~38.6) |